Changes in Work Impairment and Associated Cost Savings Among Employees Receiving Psychotherapy: Retrospective Cohort Study.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 40693923.
- Also identified by DOI 10.1097/JOM.0000000000003508 and PMC identifier 12871415.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The aim of the study was to examine changes in work impairment and associated cost savings among employees receiving psychotherapy through an employer-sponsored benefit. A retrospective analysis evaluated changes in work impairment and lost productive time among N = 5450 adults receiving psychotherapy. Per employee per year (PEPY) cost savings due to gains in productive time were estimated using a range of salary benchmarks. Employees experienced significant reductions in work impairment ( b = -2.88, 95% confidence interval [-3.01, -2.75]) and lost productive time ( b = -4.00, 95% confidence interval [-4.25, -3.74]). Based on the median US salary, improvements corresponded to an average cost savings of $4806 PEPY. Cost savings increased with increasing baseline work impairment severity (very severe: $20,882 PEPY at the median US salary). Employees receiving evidence-based psychotherapy experience meaningful reductions in work impairment, which are associated with employer cost savings due to productive time gains.
Medical subject headings
- Cost Savings
- Psychotherapy